K-Bro Linen Inc reports 18.6 pp EBITDA Margin decline from 18.6% to in 2016
24.03.2017 • About K-Bro Linen Inc (
$KBL) • By InTwits
K-Bro Linen Inc reported FY2016 financial results today. Below you can find a comprehensive analysis of the key data driving the company's performance and stock price.
K-Bro Linen Inc ($KBL) key annual financial indicators
mln. CAD | 2012 | 2013 | 2014 | 2015 | 2016 | 2016/2015 |
---|
P&L
|
---|
Revenue | 126.3 | 131.2 | 136.4 | 144.5 | 159.1 | 10.1% |
EBITDA | 24.5 | 23.3 | 26.2 | 27.0 | | -100.0% |
Net Income | 11.1 | 10.3 | 12.2 | 12.1 | 11.5 | -4.5% |
Balance Sheet
|
---|
Cash | 0.0 | 0.0 | 13.7 | 0.0 | | |
Short Term Debt | 0.0 | 0.0 | 0.0 | 0.0 | | |
Long Term Debt | 5.8 | 19.6 | 0.0 | 2.3 | | -100.0% |
Cash flow
|
---|
Capex | 12.7 | 24.9 | 15.5 | 24.0 | | -100.0% |
Ratios
|
---|
Revenue growth | 8.1% | 3.9% | 4.0% | 5.9% | 10.1% | |
EBITDA growth | 22.9% | -4.9% | 12.5% | 2.7% | | |
EBITDA Margin | 19.4% | 17.8% | 19.2% | 18.6% | 0.0% | -18.6% |
Net Income Margin | 8.8% | 7.9% | 8.9% | 8.3% | 7.2% | -1.1% |
CAPEX, % of revenue | 10.0% | 19.0% | 11.4% | 16.6% | | -16.6% |
ROIC | 20.3% | 17.2% | 16.4% | 14.7% | | -14.7% |
ROE | 17.1% | 14.9% | 13.5% | 10.8% | | -10.8% |
Net Debt/EBITDA | 0.2x | 0.8x | -0.5x | 0.1x | | -0.1x |
K-Bro Linen Inc ($KBL) key quoterly financial indicators
mln. CAD | FY16Q1 | FY16Q2 | FY16Q3 | FY16Q4 | YoY change |
---|
P&L
|
---|
Revenue | 39 | 39 | 42 | 39 | 14.8% | 11.7% | 10.2% | 4.2% |
EBITDA | 7 | 8 | 8 | 6 | 7.5% | 6.3% | -0.5% | 5.0% |
Net Income | 3 | 3 | 3 | 2 | -16.1% | 11.4% | -11.4% | 1.8% |
Balance Sheet
|
---|
Cash | 0 | 0 | 0 | 0 | -100.0% | -100.0% | -100.0% | |
Short Term Debt | 0 | 0 | 0 | 0 | | | | |
Long Term Debt | 6 | 7 | 10 | 26 | | | | 998.3% |
Ratios
|
---|
EBITDA Margin | 17.5% | 19.0% | 18.1% | 16.1% | -1.2% | -1.0% | -1.9% | 0.1% |
Net Income Margin | 6.5% | 8.6% | 8.2% | 5.6% | -2.4% | -0.0% | -2.0% | -0.1% |
Revenue and profitability
K-Bro Linen Inc's Revenue surged on 10.1%. Revenue growth showed slow down in FY16Q4 - it was 4.2% YoY.
Net Income marign decreased slightly on 1.1 pp from 8.3% to 7.2% in FY2016.
Appendix 1: Peers in Consumer, Non-cyclical
Below you can find K-Bro Linen Inc benchmarking vs. other companies in Consumer, Non-cyclical industry. It's shown for the period of 5 years for the key financial metrics. Each table has median value for all the companies in the industry together with individual financial data of the top-5 companies in the industry by particular financial metric.
Top companies by Revenue growth, %
Top 5 | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 |
---|
Concordia Healthcare Corp ($CXR) | | | 159.5% | 275.7% | 107.0% |
Heritage Global Inc ($HGP) | | -37.0% | 76.2% | 11.2% | 80.8% |
EnerCare Inc ($ECI) | | 8.6% | 21.1% | 55.7% | 76.6% |
CRH Medical Corp ($CRH) | | 12.5% | 56.0% | 284.2% | 70.2% |
Nuvo Research Inc ($NRI) | | -25.3% | -29.1% | 57.0% | 31.9% |
|
---|
Median (40 companies) | | 9.1% | 13.9% | 15.6% | 12.8% |
---|
K-Bro Linen Inc ($KBL) | | 3.9% | 4.0% | 5.9% | 10.1% |
Top companies by Gross margin, %
Top 5 | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 |
---|
Cipher Pharmaceuticals Inc ($CPH) | | 99.5% | 98.3% | 92.7% | |
Ritchie Bros Auctioneers Inc ($RBA) | 88.7% | 88.4% | 88.0% | 89.1% | 88.3% |
Information Services Corp ($ISV) | 77.5% | 80.4% | 80.9% | 87.6% | 85.1% |
Biosyent Inc ($RX) | 79.3% | 79.2% | 78.1% | 78.7% | |
Concordia Healthcare Corp ($CXR) | | 79.4% | 86.0% | 76.1% | 72.9% |
|
---|
Median (35 companies) | 32.5% | 37.1% | 35.7% | 35.7% | 31.1% |
---|
Top companies by EBITDA margin, %
Top 5 | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 |
---|
CRH Medical Corp ($CRH) | 21.0% | 24.5% | 29.1% | 44.1% | |
Valeant Pharmaceuticals International Inc ($VRX) | 30.6% | 27.8% | 45.6% | 39.8% | 23.8% |
Concordia Healthcare Corp ($CXR) | | 43.7% | 37.0% | 39.8% | -92.8% |
Ritchie Bros Auctioneers Inc ($RBA) | 36.8% | 36.3% | 36.4% | 39.7% | 31.4% |
EnerCare Inc ($ECI) | 52.8% | 51.0% | 45.5% | 39.3% | 26.6% |
|
---|
Median (43 companies) | 9.1% | 12.0% | 12.7% | 11.0% | 10.1% |
---|
K-Bro Linen Inc ($KBL) | 19.4% | 17.8% | 19.2% | 18.6% | |
Top companies by CAPEX/Revenue, %
Top 5 | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 |
---|
ProMetic Life Sciences Inc ($PLI) | 2.1% | 33.6% | 34.6% | 23.3% | |
EnerCare Inc ($ECI) | 25.7% | 26.5% | 23.6% | 20.7% | 15.5% |
Black Diamond Group Ltd ($BDI) | 61.9% | 27.5% | 31.0% | 17.6% | |
easyhome Ltd ($EH) | 32.2% | 25.6% | 21.6% | 16.9% | 12.7% |
TearLab Corp ($TLB) | 14.4% | 19.8% | 12.3% | 13.5% | |
|
---|
Median (42 companies) | 3.1% | 2.7% | 2.3% | 2.3% | 2.1% |
---|
K-Bro Linen Inc ($KBL) | 10.0% | 19.0% | 11.4% | 16.6% | |
Top companies by ROIC, %
Top 5 | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 |
---|
Information Services Corp ($ISV) | 71.8% | 72.8% | 58.9% | 38.1% | 27.6% |
Colliers International Group Inc ($CIG) | 10.5% | 11.2% | 15.2% | 10.9% | 26.1% |
Nuvo Research Inc ($NRI) | -11.6% | -17.4% | -37.9% | 12.9% | 20.8% |
International Road Dynamics Inc ($IRD) | 0.9% | 6.7% | 4.4% | 10.6% | 16.5% |
Premium Brands Holdings Corp ($PBH) | 10.3% | 9.9% | 6.9% | 12.6% | 15.3% |
|
---|
Median (43 companies) | 8.6% | 7.5% | 8.4% | 6.3% | 8.0% |
---|
K-Bro Linen Inc ($KBL) | 20.3% | 17.2% | 16.4% | 14.7% | |
Top companies by Net Debt / EBITDA
Top 5 | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 |
---|
Concordia Healthcare Corp ($CXR) | | -1.3x | 5.6x | 20.2x | |
SunOpta Inc ($SOY) | 2.9x | 3.5x | 1.3x | 16.9x | 140.8x |
Centric Health Corp ($CHH) | 5.6x | 10.2x | 11.2x | 15.6x | |
Sienna Senior Living Inc ($SIA) | 9.5x | 11.8x | 9.2x | 9.1x | 9.1x |
Valeant Pharmaceuticals International Inc ($VRX) | 9.5x | 10.4x | 4.0x | 7.3x | 12.7x |
|
---|
Median (37 companies) | 2.9x | 2.3x | 3.5x | 2.8x | 2.8x |
---|
K-Bro Linen Inc ($KBL) | 0.2x | 0.8x | -0.5x | 0.1x | |